Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - TOTAL RECEIVABLES
Total Receivables PRPH - ProPhase Labs, Inc.
36.3 M
LAST VALUE
-1.87%
2 YEAR CAGR
36.02%
5 YEAR CAGR
21.18%
10 YEAR CAGR